You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Figure EYE-1. Cannabis prevalence rates [see all figures in this series...]
Part (xii) Comparision of trends in average (unweighted) lifetime prevalence of cannabis (%) among 15-16 year old school students in Europe, USA and Australia
Notes:
Countries are grouped by (unweighted) LTP cannabis in 2007 survey.
Spain did not participate in the ESPAD survey. The data included here is based on a Spanish survey conducted in 2006/2007. Drug prevalence questions may be considered comparable to the ESPAD questions but other aspects of the method mean that the Spanish data is not strictly comparable. Belgium data is based on Flanders only. German data is based on seven regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania, Saarland and Thuringia). ESPAD 2007 data for Denmark limited comparability.
* In Australian survey the age range is 16-17, prevalence is therefore expected to be higher than for 15-16 year olds. Surveys conducted in 1996, 1999, 2002 and 2005
Sources:
Hibell et al, ESPAD surveys 1995, 1999, 2003, 2007
(see the help page for information about formats etc.)